Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollution | 5 | 2024 | 218 | 1.900 |
Why?
|
| Particulate Matter | 4 | 2024 | 247 | 1.130 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 287 | 0.800 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 334 | 0.710 |
Why?
|
| Brain Ischemia | 1 | 2023 | 321 | 0.660 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 1213 | 0.600 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 1001 | 0.550 |
Why?
|
| Models, Statistical | 1 | 2021 | 625 | 0.550 |
Why?
|
| Air Pollutants | 4 | 2024 | 314 | 0.520 |
Why?
|
| Medicare | 5 | 2024 | 708 | 0.510 |
Why?
|
| Stroke | 2 | 2023 | 1071 | 0.490 |
Why?
|
| Research Design | 1 | 2021 | 1045 | 0.470 |
Why?
|
| Environmental Exposure | 4 | 2024 | 463 | 0.400 |
Why?
|
| Heart Failure | 1 | 2023 | 2133 | 0.340 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 2 | 2019 | 19 | 0.300 |
Why?
|
| United States | 10 | 2025 | 13871 | 0.250 |
Why?
|
| Aged | 12 | 2025 | 22061 | 0.240 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 32 | 0.220 |
Why?
|
| Hypnotics and Sedatives | 1 | 2025 | 175 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 2442 | 0.210 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 60 | 0.200 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2019 | 467 | 0.200 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 151 | 0.200 |
Why?
|
| Biguanides | 1 | 2022 | 12 | 0.200 |
Why?
|
| Selection Bias | 1 | 2022 | 37 | 0.200 |
Why?
|
| Calibration | 1 | 2022 | 140 | 0.190 |
Why?
|
| Poverty | 2 | 2023 | 499 | 0.190 |
Why?
|
| Causality | 1 | 2022 | 117 | 0.190 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 679 | 0.190 |
Why?
|
| Entropy | 1 | 2021 | 39 | 0.180 |
Why?
|
| Temperature | 1 | 2024 | 637 | 0.180 |
Why?
|
| Social Class | 1 | 2023 | 259 | 0.180 |
Why?
|
| Food Assistance | 1 | 2021 | 29 | 0.170 |
Why?
|
| Probability | 1 | 2021 | 306 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 242 | 0.170 |
Why?
|
| Coronary Angiography | 2 | 2019 | 306 | 0.170 |
Why?
|
| Fruit | 1 | 2021 | 133 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 524 | 0.170 |
Why?
|
| Vegetables | 1 | 2021 | 148 | 0.160 |
Why?
|
| Machine Learning | 2 | 2022 | 443 | 0.160 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 260 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 2006 | 0.160 |
Why?
|
| Humans | 19 | 2025 | 129625 | 0.160 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 275 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2024 | 637 | 0.160 |
Why?
|
| Hypoglycemia | 1 | 2024 | 427 | 0.160 |
Why?
|
| Myocardial Infarction | 2 | 2024 | 1021 | 0.160 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 72 | 0.150 |
Why?
|
| Metformin | 1 | 2022 | 318 | 0.150 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2025 | 623 | 0.150 |
Why?
|
| Eating | 1 | 2021 | 368 | 0.150 |
Why?
|
| Hospitalization | 2 | 2024 | 2057 | 0.140 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 179 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2025 | 984 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2024 | 14522 | 0.140 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 52 | 0.130 |
Why?
|
| Aspirin | 1 | 2019 | 380 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2019 | 402 | 0.120 |
Why?
|
| Diet | 1 | 2021 | 1213 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1914 | 0.100 |
Why?
|
| Quality of Life | 1 | 2023 | 2688 | 0.090 |
Why?
|
| Male | 9 | 2025 | 63670 | 0.090 |
Why?
|
| Hot Temperature | 2 | 2024 | 370 | 0.090 |
Why?
|
| Female | 9 | 2025 | 68734 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 7052 | 0.090 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 1221 | 0.080 |
Why?
|
| Middle Aged | 7 | 2025 | 31136 | 0.070 |
Why?
|
| Blood Glucose | 3 | 2022 | 2100 | 0.070 |
Why?
|
| Adult | 3 | 2024 | 35599 | 0.060 |
Why?
|
| Melatonin | 1 | 2025 | 125 | 0.060 |
Why?
|
| Taiwan | 1 | 2024 | 19 | 0.060 |
Why?
|
| Insulin, Regular, Human | 1 | 2024 | 43 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2023 | 62 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 122 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 5426 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 520 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 2564 | 0.050 |
Why?
|
| San Francisco | 1 | 2021 | 51 | 0.050 |
Why?
|
| Life Style | 1 | 2023 | 461 | 0.050 |
Why?
|
| Los Angeles | 1 | 2021 | 63 | 0.040 |
Why?
|
| Urban Health | 1 | 2021 | 79 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1198 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2024 | 680 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 39 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 2641 | 0.040 |
Why?
|
| Weight Loss | 1 | 2023 | 738 | 0.040 |
Why?
|
| No-Reflow Phenomenon | 1 | 2017 | 7 | 0.040 |
Why?
|
| Veterans Health | 1 | 2019 | 177 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 1005 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 60 | 0.030 |
Why?
|
| Risk | 1 | 2019 | 855 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2017 | 120 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 515 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 9786 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1365 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 443 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 10219 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 851 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1019 | 0.030 |
Why?
|
| Insulin | 1 | 2024 | 2326 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 848 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 458 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 1986 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2882 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 3152 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 1899 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3262 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6555 | 0.020 |
Why?
|